BCL2 and cancer: Among these six genes, there are four three cancer genes: MYC, BCL2, and KDSR. BCL2 and MYC show differential expression in patients with decrease in loop probabilities vs. the other patients (Fig. 4 c, d; Wilcoxon signed-rank test).